DermTech Ownership
| DMTKDelisted Stock | USD 0.04 0.02 71.36% |
DermTech |
DermTech Stock Ownership Analysis
About 18.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.02. Some equities with similar Price to Book (P/B) outperform the market in the long run. DermTech recorded a loss per share of 2.65. The entity last dividend was issued on the 30th of August 2019. The firm had 1:2 split on the 30th of August 2019. DermTech, Inc., a molecular diagnostic company, develops and markets novel non-invasive genomics tests to diagnosis skin cancer, inflammatory diseases, and aging-related conditions in the United States. The company sells its products primarily to pathology and oncology practitioners. Dermtech operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 255 people. To learn more about DermTech call John MD at 858 450 4222 or check out https://www.dermtech.com.DermTech Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific DermTech insiders, such as employees or executives, is commonly permitted as long as it does not rely on DermTech's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases DermTech insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Sun Kevin M over six months ago Disposition of 445 shares by Sun Kevin M of DermTech at 0.34 subject to Rule 16b-3 | ||
Akhavan Ramin over six months ago Disposition of 1757 shares by Akhavan Ramin of DermTech at 0.31 subject to Rule 16b-3 | ||
Sun Kevin M over six months ago Disposition of 2530 shares by Sun Kevin M of DermTech at 0.31 subject to Rule 16b-3 | ||
Todd Wood over six months ago Acquisition by Todd Wood of 85114 shares of DermTech subject to Rule 16b-3 | ||
Sun Kevin M over six months ago Disposition of 445 shares by Sun Kevin M of DermTech at 0.7 subject to Rule 16b-3 | ||
Sun Kevin M over six months ago Disposition of 2531 shares by Sun Kevin M of DermTech at 0.88 subject to Rule 16b-3 | ||
Sun Kevin M over a year ago Sale by Sun Kevin M of 223 shares of DermTech | ||
Sun Kevin M over a year ago Sale by Sun Kevin M of 514 shares of DermTech | ||
Sun Kevin M over a year ago Sale by Sun Kevin M of 198 shares of DermTech |
DermTech Outstanding Bonds
DermTech issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. DermTech uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most DermTech bonds can be classified according to their maturity, which is the date when DermTech has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Other Consideration for investing in DermTech Stock
If you are still planning to invest in DermTech check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the DermTech's history and understand the potential risks before investing.
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |